Business
US pharma company Eli Lilly pauses trial of antibody drug Trump touted as COVID-19 ‘cure’ – Sydney Morning Herald
Eli Lilly’s announcement comes one day after Johnson & Johnson said it was forced to pause a large high-profile trial of its experimental coronavirus vaccine be…
Lilly said earlier this month it was applying for emergency use authorisation (EUA) for the antibody drug, LY-CoV555, for patients with mild to moderate COVID-19 based on data from another clinical trial.
It is not uncommon to pause drug trials to investigate safety concerns, and such actions do not necessarily indicate a serious problem. Because of the urgent need for drugs and vaccines to tackle a pandemic that has claimed over 1 million lives worldwide – and the speed with which they are bei…
-
General13 hours agoPeople left in limbo after fire rips through Storage King facility in Burpengary, north of Brisbane
-
Noosa News13 hours agoBrisbane news LIVE updates: Burpengary storage facility engulfed in fire | Toll road laws passed in Parliament
-
General20 hours agoWhite phosphorus, blood-red money. Australian Super profiting from genocide
-
General20 hours agoIsraeli fire kills 41 in Gaza, health officials say, as rival militia emerges to challenge Hamas